Maureen Van Den Donk
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Application of new glucose lowering drugs: DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors
Journal: Nederlands tijdschrift voor geneeskunde
Published: January 25, 2019
Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control.
Journal: The Cochrane database of systematic reviews
Published: September 19, 2016
A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.
Journal: Health technology assessment (Winchester, England)
Published: September 02, 2016
New oral anticoagulants for nonvalvular atrial fibrillation in the elderly: Limited applicability in primary care.
Journal: The European journal of general practice
Published: December 16, 2014
Impact of UKPDS risk estimation added to a first subjective risk estimation on management of coronary disease risk in type 2 diabetes - An observational study.
Journal: Primary care diabetes
Published: October 23, 2014
New oral anticoagulants in patients with atrial fibrillation.
Journal: Lancet (London, England)
Published: July 08, 2014
Important changes in the Dutch College of General Practitioners (NHG) practice guideline 'Atrial fibrillation': revised practice guideline issued
Journal: Nederlands tijdschrift voor geneeskunde
Published: December 17, 2013
Summary of the NHG practice guideline 'Lower urinary tract symptoms in men'
Journal: Nederlands tijdschrift voor geneeskunde
Published: May 03, 2013
Effect of early intensive multifactorial therapy compared with routine care on self-reported health status, general well-being, diabetes-specific quality of life and treatment satisfaction in screen-detected type 2 diabetes mellitus patients (ADDITION-Europe): a cluster-randomised trial.
Journal: Diabetologia
Published: April 22, 2013
Last Updated: 09/26/2026